2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist

In the present paper we describe 2-methyl-6-(phenylethynyl)-pyridine (MPEP) as a potent, selective and systemically active antagonist for the metabotropic glutamate receptor subtype 5 (mGlu5). At the human mGlu5a receptor expressed in recombinant cells, MPEP completely inhibited quisqualate-stimulated phosphoinositide (PI) hydrolysis with an IC50 value of 36 nM while having no agonist or antagonist activities at cells expressing the human mGlu1b receptor at concentrations up to 30 microM. When tested at group II and III receptors, MPEP did not show agonist or antagonist activity at 100 microM on human mGlu2, -3, -4a, -7b, and -8a receptors nor at 10 microM on the human mGlu6 receptor. Electrophysiological recordings in Xenopus laevis oocytes demonstrated no significant effect at 100 microM on human NMDA (NMDA1A/2A), rat AMPA (Glu3-(flop)) and human kainate (Glu6-(IYQ)) receptor subtypes nor at 10 microM on the human NMDA1A/2B receptor. In rat neonatal brain slices, MPEP inhibited DHPG-stimulated PI hydrolysis with a potency and selectivity similar to that observed on human mGlu receptors. Furthermore, in extracellular recordings in the CA1 area of the hippocampus in anesthetized rats, the microiontophoretic application of DHPG induced neuronal firing that was blocked when MPEP was administered by iontophoretic or intravenous routes. Excitations induced by microiontophoretic application of AMPA were not affected.

[1]  D. Laurie,et al.  (R,S)-4-phosphonophenylglycine, a potent and selective group III metabotropic glutamate receptor agonist, is anticonvulsive and neuroprotective in vivo. , 1999, The Journal of pharmacology and experimental therapeutics.

[2]  H. Sugiyama,et al.  3,5-Dihydroxyphenyl-glycine: a potent agonist of metabotropic glutamate receptors. , 1992, Neuroreport.

[3]  G. Collingridge,et al.  (RS)-2-Chloro-5-Hydroxyphenylglycine (CHPG) Activates mGlu5, but not mGlu1, Receptors Expressed in CHO Cells and Potentiates NMDA Responses in the Hippocampus , 1997, Neuropharmacology.

[4]  J. Pin,et al.  Pharmacology and functions of metabotropic glutamate receptors. , 1997, Annual review of pharmacology and toxicology.

[5]  S. Heinemann,et al.  Ca2+ permeability of KA-AMPA--gated glutamate receptor channels depends on subunit composition , 1991, Science.

[6]  Serge Charpak,et al.  Potassium conductances in hippocampal neurons blocked by excitatory amino-acid transmitters , 1990, Nature.

[7]  P. Conn,et al.  Multiple presynaptic metabotropic glutamate receptors modulate excitatory and inhibitory synaptic transmission in hippocampal area CA1 , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[8]  T. Knöpfel,et al.  Profiling of trans-azetidine-2,4-dicarboxylic acid at the human metabotropic glutamate receptors mGlu1b, -2, -4a and -5a. , 1995, European journal of pharmacology.

[9]  Johan F. Storm,et al.  Functional diversity of K+ currents in hippocampal pyramidal neurons , 1993 .

[10]  K. Lingenhöhl,et al.  Reevaluation of ACEA 1021 as an antagonist at the strychnine-insensitive glycine site of the N-methyl-d-aspartate receptor , 1998, Neuropharmacology.

[11]  T. Knöpfel,et al.  A Novel Splice Variant of a Metabotropic Glutamate Receptor, Human mGluR7b , 1997, Neuropharmacology.

[12]  K. Stauderman,et al.  Fluorescence techniques for measuring ion channel activity. , 1999, Methods in enzymology.

[13]  A. Young,et al.  Cloning and stable expression of the mGluR1b subtype of human metabotropic receptors and pharmacological comparison with the mGluR5a subtype , 1997, Neuropharmacology.

[14]  Shigetada Nakanishi,et al.  Immunohistochemical localization of a metabotropic glutamate receptor, mGluR5, in the rat brain , 1993, Neuroscience Letters.

[15]  T. Rao,et al.  (S)-4-carboxy-3-hydroxyphenylglycine activates phosphatidyl inositol linked metabotropic glutamate receptors in different brain regions of the neonatal rat , 1998, Neurochemistry International.

[16]  A. N. van den Pol,et al.  Distribution of metabotropic glutamate receptor mGluR5 immunoreactivity in rat brain , 1995, The Journal of comparative neurology.

[17]  T. Salt,et al.  Phenylglycine derivatives as new pharmacological tools for investigating the role of metabotropic glutamate receptors in the central nervous system , 1993, Neuroscience.

[18]  Ayae Kinoshita,et al.  Differential Presynaptic Localization of Metabotropic Glutamate Receptor Subtypes in the Rat Hippocampus , 1997, The Journal of Neuroscience.

[19]  P. Conn,et al.  Excitatory effects of ACPD receptor activation in the hippocampus are mediated by direct effects on pyramidal cells and blockade of synaptic inhibition. , 1991, Journal of neurophysiology.

[20]  S. Lazareno,et al.  Pharmacological characterization of guanine nucleotide exchange reactions in membranes from CHO cells stably transfected with human muscarinic receptors m1-m4. , 1993, Life sciences.

[21]  Atsuko Fukunaga,et al.  A novel class of antagonists for metabotropic glutamate receptors, 7-(Hydroxyimino)cyclopropa[b]chromen-1a-carboxylates , 1996 .

[22]  F. Gasparini,et al.  SIB-1757 and SIB-1893: selective, noncompetitive antagonists of metabotropic glutamate receptor type 5. , 1999, The Journal of pharmacology and experimental therapeutics.

[23]  F. Gasparini,et al.  CPCCOEt, a noncompetitive metabotropic glutamate receptor 1 antagonist, inhibits receptor signaling without affecting glutamate binding. , 1999, Molecular pharmacology.

[24]  T. Knöpfel,et al.  Metabotropic glutamate receptors: novel targets for drug development. , 1995, Journal of medicinal chemistry.

[25]  H. Tse,et al.  Structure‐activity relationships of new agonists and antagonists of different metabotropic glutamate receptor subtypes , 1996, British journal of pharmacology.

[26]  J. Disterhoft,et al.  Activation of metabotropic glutamate receptors induces long-term depression of GABAergic inhibition in hippocampus. , 1993, Journal of neurophysiology.

[27]  M. Raimondo,et al.  (S)-(+)-2-(3'-carboxybicyclo[1.1.1]pentyl)-glycine, a structurally new group I metabotropic glutamate receptor antagonist. , 1996, Journal of medicinal chemistry.

[28]  A. Young,et al.  Molecular and functional characterization of recombinant human metabotropic glutamate receptor subtype 5 , 1995, Neuropharmacology.

[29]  D. Laurie,et al.  Cloning, Distribution and Functional Expression of the Human mGlu6 Metabotropic Glutamate Receptor , 1997, Neuropharmacology.

[30]  J. Crona,et al.  Cloning and functional characterization of human heteromeric N-methyl-D-aspartate receptors. , 1996, The Journal of pharmacology and experimental therapeutics.

[31]  J. Watkins,et al.  Phenylglycine derivatives as antagonists of metabotropic glutamate receptors. , 1994, Trends in pharmacological sciences.

[32]  R. Huganir,et al.  Cellular localization of a metabotropic glutamate receptor in rat brain , 1992, Neuron.

[33]  R. Challiss,et al.  Reversible and non-competitive antagonist profile of CPCCOEt at the human type 1α metabotropic glutamate receptor , 1998, Neuropharmacology.

[34]  D. Schoepp,et al.  3,5‐Dihydroxyphenylglycine Is a Highly Selective Agonist for Phosphoinositide‐Linked Metabotropic Glutamate Receptors in the Rat Hippocampus , 1994, Journal of neurochemistry.

[35]  A. N. van den Pol,et al.  Enhanced early developmental expression of the metabotropic glutamate receptor mGluR5 in rat brain: Protein, mRNA splice variants, and regional distribution , 1996, The Journal of comparative neurology.

[36]  T. Tsuchiya,et al.  Thermal rearrangements of cyclic amine ylides. VIII: Intramolecular cyclization of 2-ethynylpyridine N-ylides into indolizines and cycl[3.2.2]azines , 1988 .

[37]  F. Nicoletti,et al.  Metabotropic glutamate receptors: a new target for the therapy of neurodegenerative disorders? , 1996, Trends in Neurosciences.